# Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

> **NCT05374317** · PHASE4 · COMPLETED · sponsor: **US Army Medical Research Institute of Infectious Diseases** · enrollment: 88 (actual)

## Conditions studied

- Yellow Fever Vaccination Reaction

## Interventions

- **BIOLOGICAL:** Yellow Fever Vaccine

## Key facts

- **NCT ID:** NCT05374317
- **Lead sponsor:** US Army Medical Research Institute of Infectious Diseases
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-07
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05374317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05374317, "Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05374317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*